N
ALXO icon

Nuveen’s ALX Oncology ALXO Stock Holding History

Nuveen’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-164,790
Closed -$103K – 3279
2025
Q1 		$103K Hold
164,790
– – ﹤0.01% 3211
2024
Q4 		$275K Buy
164,790
+58,896
+56% +$90.5K ﹤0.01% 3144
2024
Q3 		$193K Hold
105,894
– – ﹤0.01% 3230
2024
Q2 		$639K Hold
105,894
– – ﹤0.01% 2911
2024
Q1 		$1.18M Hold
105,894
– – ﹤0.01% 2631
2023
Q4 		$1.58M Buy
105,894
+18,241
+21% +$173K ﹤0.01% 2516
2023
Q3 		$421K Sell
87,653
-10,411
-11% -$56.5K ﹤0.01% 2899
2023
Q2 		$736K Hold
98,064
– – ﹤0.01% 2792
2023
Q1 		$443K Sell
98,064
-7,001
-7% -$53K ﹤0.01% 2834
2022
Q4 		$1.18M Sell
105,065
-10,556
-9% -$119K ﹤0.01% 2622
2022
Q3 		$1.11M Sell
115,621
-1,198
-1% -$14K ﹤0.01% 2707
2022
Q2 		$945K Buy
116,819
+68,193
+140% +$743K ﹤0.01% 2806
2022
Q1 		$872K Sell
48,626
-15,230
-24% -$260K ﹤0.01% 2859
2021
Q4 		$1.37M Sell
63,856
-1,329
-2% -$57.3K ﹤0.01% 2736
2021
Q3 		$4.81M Sell
65,185
-29,752
-31% -$1.98M ﹤0.01% 2234
2021
Q2 		$5.19M Buy
94,937
+8,359
+10% +$500K ﹤0.01% 2226
2021
Q1 		$6.38M Buy
86,578
+39,673
+85% +$3.12M ﹤0.01% 2048
2020
Q4 		$4.04M Buy
46,905
+10,997
+31% +$662K ﹤0.01% 2178
2020
Q3 		$1.36M Buy
+35,908
New +$1.41M ﹤0.01% 2551

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nuveen's ALXO Position: Q2 2025 in Review

Nuveen sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 164,790 shares — an estimated $103K sold.

Nuveen first reported a position in ALXO in Q3 2020 and held it in 19 quarters. The position peaked at $6.38M in Q1 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Nuveen reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 164,790 ALX Oncology shares in Q2 2025, an estimated $103K.
  • Nuveen first reported a position in ALX Oncology in Q3 2020 and held it in 19 quarters.
  • Nuveen's ALX Oncology position peaked at $6.38M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.